CLINICAL_TRIALS
trial_result
· 2020-01-18
Clinical Trial Update: CORAL XT - Open-label Extension Trial of the CORAL Trial [Phase 3]
Summary
Open-label extension of a Phase 3 CORAL trial completed; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Tris Pharma, Inc. | Conditions: Pain, Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2020-01-18